China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing 100700, Peoples R China
通讯作者
Wang Yanping, Wang Yongyan
来源期刊
J Tradit Chin Med
ISSN
0255-2922
EISSN
1577-7014
出版日期
1981-12-15
卷号
40
期号
6
页码
891-896
摘要
OBJECTIVE: To summarize the evidence from Traditional Chinese Medicine (TCM) practice in the treatment of coronavirus disease 2019 (COVID-19) and provide timely clinical practice guidance.
METHODS: The guidelines were developed in accordance with the World Health Organization rapid guideline process. The evidence on TCM for COVID-19 from published guidelines, direct and indirect published clinical evidence, first hand clinical data, and expert experience and consensus were collected. The grading of recommendations assessment, development and evaluation (GRADE) method was used to grade the evidence and make the recommendations.
RESULTS: Based on the available evidence, the guidelines recommended 17 Chinese medicines for COVID-19: 2 Chinese herbal granules, 7 Chinese patent medicines, and 8 Chinese herbal injections.
CONCLUSION: As the literature search was conducted on March, any subsequent versions of these guidelines require an up-to-date literature review. We hope that the evidence summary in these guidelines will be helpful in global efforts to address COVID-19. (C) 2020 JTCM. All rights reserved.
Supported by National Key Research & Development Program of China: Research on the Development and Evaluation of International Standards of Traditional Chinese Medicine (No. 2019YFC1712000; 2019YFC1712005; 2019YFC1712003); National Science and Technology Major Project: "The Belt and Road" Popularization and Application of Traditional Chinese Medicine Clinical Diagnosis and Treatment Project for Infectious Diseases (No. 2018ZX10101001-005-003; 2018ZX10101001-005-004)
